Celea Therapeutics

Series-A
celeatx.com Biotech & Healthcare Boston, United States 11-50
Total Funding $180M
Latest Round $180M Series-A
Last Announced Jul 2, 2026
Investors 3 Backers
Decision Makers 6 Verified

About Celea Therapeutics

Celea Therapeutics develops drug therapies for serious respiratory and fibrotic lung diseases. The company focuses on idiopathic pulmonary fibrosis (IPF) and is advancing deupirfenidone, an oral investigational therapy. Its customers are patients and physicians.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Boston, United States
Team Size 11-50
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website celeatx.com
Domain Registered Date Aug 8, 2025

Social & Network Presence

X / Twitter Profile @CeleaTx (8 followers) Created on Aug 2025
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $180,000,000 · Series-A

    fundraisingfox.com

  2. Milestone

    Website domain registered

    celeatx.com

  3. Milestone

    X account created (@CeleaTx)

    8 followers

Investors & Backers

3
Leaps by Bayer
PureTech Health
RA Capital Management

Funding History

1 Round
Series-A · Jul 2, 2026

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts